Orthopedic imaging relies on X-ray, MRI and CT to diagnose disorders and injuries affecting the bones, muscles, ligaments, tendons, cartilage, and spine. Orthopedists also use these test results to create an effective treatment plan.
Genicular artery embolization targets synovial blood vessel abnormalities believed to cause painful inflammation that contributes to the severe discomfort most patients experience with OA.
The goal of the study is to obtain quantitative data on how daily training and competing affect players’ musculoskeletal health. The information will be used to inform training, rest and recovery periods.
Although gadolinium-based contrast agents are largely considered safe and are routinely used for MRI exams, experts suggest that providers should still utilize GBCAs sparingly for musculoskeletal studies.
Patients who received an injection had an infection rate of 2.2% at 4-month follow-up. In comparison, the infection rate for the general population in Massachusetts was 7.5% during the same period.
Established clinical guidelines hold that patients presenting with ankle issues should not receive advanced imaging ahead of standard radiography. New research shows a substantial proportion of ordering clinicians sending these patients straight to MRI anyway.
“These findings emphasize the importance of early recognition of IPV and timely intervention to prevent further harm to the victim,” authors of research published in Academic Radiology cautioned.
Because sacral insufficiency fractures do not always show a fracture line, they can be difficult to diagnose or even misdiagnosed as bone metastasis, which could result in additional treatments like radio-chemotherapy.
A study in Lancet Digital Health reports that a previously validated, high performing AI model committed troublesome errors when confronted with atypical anatomy.
The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.
GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.
Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.